Clinical Trial Update: Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum Disorders [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating NPC-15 for sleep disorders in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Sleep Disorders

Drugs mentioned

• NPC-15

Snippet

Sponsor: Nobelpharma | Conditions: Sleep Disorders, Autism Spectrum Disorder | Phase 2, Phase 3 | Status: COMPLETED